Article

FDA clearance granted for femtosecond laser

A new femtosecond laser (iFS, Advanced Medical Optics), which, according to its manufacturer is capable of creating a corneal flap during LASIK in less than 10 seconds, has received FDA clearance.

Santa Ana, CA-A new femtosecond laser (iFS, Advanced Medical Optics), which, according to its manufacturer is capable of creating a corneal flap during LASIK in less than 10 seconds, has received FDA clearance. It has been designed to increase postoperative flap adhesion and enhance the biomechanical stability of the post-LASIK cornea.

Some additional features of the laser, according to the company, include a higher repetition rate, tighter spot separation, lower energy, a high-resolution digital video microscope, a new user interface, a keyboard and touch screen, and ergonomic design for maximum surgeon comfort.

"The . . . laser builds upon an 8-year history of innovation and more than two million IntraLase femtosecond procedures performed worldwide," said American Medical Optics (AMO) chairman and chief executive officer Jim Mazzo. "This technology is an integral part of AMO?s proprietary iLASIK technology suite and a tangible example of our commitment to not only maintain a substantial advantage over competing systems, but also to provide technologies that advance the standard of vision care medically."

"The new . . . laser provides the surgeon with the ability to select LASIK flap dimensions customizable to individual refractive errors and corneal anatomy with capabilities such as the elliptical flap option, inverted bevel-in side cut angle, and increased speed," said Perry S. Binder, MD, of the Gordon Binder Weiss Vision Institute in San Diego. "This exciting new laser, combined with the iLASIK technology suite, provides the surgeon with the most advanced technologies to give their patients the safest and best outcomes."

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.